| Part 1. Single substance application | Part 2. Combined substance applicationa | ||
---|---|---|---|---|
Cap-group | LA-group | Cap/LA-group | LA/Cap-group | |
(n = 14) | (n = 14) | (n = 14) | (n = 14) | |
gender (female, n (%)) | 9 (64%) | 8 (57%) | 9 (64%) | 8 (57%) |
age (years, mean ± SD) | 30 ± 14 | 30 ± 13 | 31 ± 13 | 30 ± 14 |
BMI (kg/m2) | 23 ± 2 | 24 ± 4 | 23 ± 3 | 24 ± 3 |
HADS A-Score | 3.9 ± 2.3 | 2.9 ± 2.0 | 2.9 ± 2.1 | 3.8 ± 2.3 |
HADS D-Score | 1.5 ± 1.6 | 0.6 ± 0.9 | 0.9 ± 1.2 | 1.3 ± 1.5 |
Pain sensitivity score (PSQ), total | 2.7 ± 0.9 | 2.5 ± 0.9 | 2.5 ± 0.8 | 2.7 ± 1 |
Pain catastrophizing scale (PCS), total | 7.1 ± 8.2 | 10.1 ± 7.4 | 8.5 ± 7.7 | 8.6 ± 8.2 |
Duration of acute capsaicin-induced pain (min) | 32 ± 7*** | not applicable | 83 ± 30.8*** | 48 ± 14***c |
Mean spontaneous pain intensity after capsaicin gauze removal (NRS 0-10) | 6.7 ± 1.3 | not applicable | 6.7 ± 1.8 | 6.4 ± 1.9 |
Duration of reported hypersensitivity after capsaicin application (days) | 1 ± 0.5 | not applicable | 0.8 ± 0.5 | 0.9 ± 0.5 |
Area of allodynia (cm2) | 60 ± 39* | not applicable | 32 ± 22* | 48 ± 17* |
Area of pinprick hyperalgesia (cm2) | 66 ± 43 | not applicable | 57 ± 30 | 54 ± 25 |
Area of tactile hypoesthesia (cm2) | not applicable | 9 ± 4 | not applicable | not applicable |
Skin temperature change after removal of the applied substances (Δ °C)b | 1.4 ± 1.4 | -1.1 ± 1.1** | 0.7 ± 1.5 | 1.8 ± 1.7 |